Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celsion Provides Encouraging Post-Hoc O/S Data From HEAT Trial
Seeking Alpha
Monday, January 27, 2014 - 11:52am
tags:
Celsion, cancer, drug delivery, clinical trials
Geron Shares React to Imetelstat Mayo Study Update
TheStreet.com
Monday, January 27, 2014 - 9:24am
tags:
Geron, imetelstat, myelofibrosis
Piper Jaffray’s Seven Biotech Stocks to Buy With Huge Potential Upside
Wall St 24/7
Monday, January 27, 2014 - 9:21am
tags:
Avanir, BioDelivery Sciences, Conatus Pharmaceuticals, Geron, Halozyme, Neurocrine, Orexigen
Evoke Pharma Moves Full Speed Ahead
Seeking Alpha
Monday, January 27, 2014 - 9:17am
tags:
Evoke Pharma, diabetes, metoclopramide, EVK-001, GSK, Theravance, Salix
Johnson & Johnson's Prospects in 2014
Motley Fool
Monday, January 27, 2014 - 9:15am
tags:
JNJ
What Are AstraZeneca plc’s Dividend Prospects Like Beyond 2014?
Motley Fool
Monday, January 27, 2014 - 9:14am
tags:
AstraZeneca, dividends
Novartis: Running Fast to Stand Still?
Motley Fool
Monday, January 27, 2014 - 9:11am
tags:
Novartis, acute heart failure, serelaxin
Did Roche's Press Release Jeopardize The Ongoing Clinical Trials For Its Schizophrenia Drug, Bitopertin?
Forbes
Monday, January 27, 2014 - 8:59am
tags:
schizophrenia, Roche, clinical trials, bitopertin
Pfizer cancer drug fails in 2 late-stage studies, results from 3rd trial expected in 2015
Yahoo/AP
Monday, January 27, 2014 - 8:54am
tags:
Pfizer, dacomitinib, erlotinib, non-small cell lung cancer
Liver Drug Race: Intercept Pharma Vs. Rivals
Seeking Alpha
Monday, January 27, 2014 - 8:21am
tags:
Intercept Pharma, liver disease, OCA, Conatus Pharmaceuticals, Gilead Sciences, Galectin, NASH, non-alcoholic fatty liver disease
Arena Investors Await Strong Sales Data
Seeking Alpha
Monday, January 27, 2014 - 8:17am
tags:
Arena Pharmaceuticals, Belviq, Eisai, Orexigen, Vivus
Teva Plunge Short-Lived to Bernstein Amid Board Overhaul
Businessweek
Sunday, January 26, 2014 - 11:23am
tags:
Teva Pharmaceuticals
Pfizer Inc. Earnings: Can the Big Pharma Stock Keep Recovering?
Motley Fool
Sunday, January 26, 2014 - 11:20am
tags:
Pfizer, earnings
GlaxoSmithKline's Eperzan Gets Closer to Launch
Motley Fool
Sunday, January 26, 2014 - 10:53am
tags:
GSK, Eperzan, diabetes, type 2 diabetes
This Week in Biotech: Clinical Success, Plus Wheeling and Dealing
Motley Fool
Sunday, January 26, 2014 - 10:46am
tags:
BioDelivery Sciences, Endo Health Solutions, Karyopharm Therapeutics, Repligen, Biomarin, Ariad Pharmaceuticals, Eli Lilly, GSK, Shire
This Biotech Powerhouse Could Land Traders Double-Digit Profits
Yahoo/Street Authority
Sunday, January 26, 2014 - 10:43am
tags:
Biogen Idec
Seattle Genetics Will Exceed And Immunogen Will Meet Market Expectations
Seeking Alpha
Sunday, January 26, 2014 - 10:41am
tags:
Seattle Genetics, Immunogen
Teva’s Laquinimod MS Pill Fails to Win EU Agency Backing
Bloomberg
Saturday, January 25, 2014 - 11:39am
tags:
Teva Pharmaceuticals, MS, multiple sclerosis, Active Biotech, laquinimod
Teva Pharma (TEVA) + Active Biotech (ACTI) = Firmly Committed to NERVENTRA Program
Street Insider
Saturday, January 25, 2014 - 11:34am
tags:
Teva Pharmaceuticals, Active Biotech, Nerventra, laquinimod, MS, multiple sclerosis
Big Pharmas Battle For The Billion-Dollar Melanoma Market
Seeking Alpha
Saturday, January 25, 2014 - 11:20am
tags:
melanoma, Bristol-Myers Squibb, Merck

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.